Thousands more patients with multiple sclerosis in England will soon be able to access Merck KGaA's take-at-home tablet Mavenclad, reducing their need for clinic visits. New guidance (PDF) from health ...
Microsoft surged nearly 9% in premarket trading after fiscal Q4 earnings of $3.65 per share and revenue of $76.44 billion, both topping estimates. Azure cloud revenue strength and sustained AI demand ...
Sector & Thematic ETFs: Rotations, Megatrends and How to Play Them Traders await Fed’s signal on future rate cuts after today’s expected 25bps move and data blackout uncertainty. Meta, Microsoft, and ...
Joel O’Leary is a full-time Personal Finance Writer at Motley Fool Money, covering credit cards, bank accounts, investing, mortgages, and other personal finance topics. Joel has been writing about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results